Skip to content
logo

MD Pharma Consulting Group

Physicians Committed to Patient Safety

+1-905-315-5043 or
info@mdpharma.ca
  • Home
  • Clinical Services
    • Pharmacovigilance
    • Statistics & Data Analysis
    • Clinical Operations
    • Medical Writing
    • Research & Development
  • CPD Training
  • Our Team
  • Blogs and Industry News
  • Contact Us

Archive for November 2018

Causality Assessment Methods of Hepatic Adverse Drug Reactions: Opportunities for Enhancement

November 1, 2018

Joint Event on International Conference on WORLD DRUG DELIVERY AND NOVEL THERAPY SUMMIT & Annual Congress on NEUROSCIENCE & THERAPEUTICS October 25-26, 2018 | Toronto, Canada Conference Date: October 25-26, 2018 Conference Venue: Hotel Park Inn By Radisson Toronto Airport West Address: 175 Derry Rd E, Mississauga, ON L5T 2Z7, Canada Session Date: October 25,…

Read More

Categories

  • About Us
  • CPD Training
  • Industry News
  • Medical Writing
  • Pharmacovigilance
  • Research & Development

Recent Posts

  • Insulin Resistance – What does it mean?
  • 5-minute weekly newscast – 23/06/2019
  • 5-minute weekly newscast – 16/06/2019
  • 5-minute weekly newscast – 09/06/2019
  • 5-minute weekly newscast – 02/06/2019

Archives

  • June 2021
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • November 2018
  • April 2018

MD Pharma Consulting Group Follow

MD Pharma Consulting Group is a science driven quality focused leader that provides innovative consultations to diverse bio-pharmaceutical industry stakeholders

MDPharmaConsult
biocentury BioCentury @biocentury ·
6m

EMA's CHMP recommendations include new therapies Briumvi and Omvoh, and label extensions for Breyanzi and Ultomiris: a BioCentury Data Byte https://buff.ly/3nyxR7I

Reply on Twitter 1641930881173422081 Retweet on Twitter 1641930881173422081 Like on Twitter 1641930881173422081 Twitter 1641930881173422081
webmd WebMD @webmd ·
6m

Scientists who study rheumatoid arthritis have found that people who have the condition often lack vitamin D. When taken as a supplement, it could help arthritis treatment work better. Learn about other supplements for joint pain: https://wb.md/3TQ7vtS

Reply on Twitter 1641930875792244740 Retweet on Twitter 1641930875792244740 2 Like on Twitter 1641930875792244740 5 Twitter 1641930875792244740
statnews STAT @statnews ·
6m

In explaining the decision, @ministerVWS maintained that the price Gilead sought to charge for its medication, known as Trodelvy, did not justify the health benefits. https://trib.al/jK4HpnZ

Reply on Twitter 1641930873338490880 Retweet on Twitter 1641930873338490880 Like on Twitter 1641930873338490880 1 Twitter 1641930873338490880
fdaoncology FDA Oncology @fdaoncology ·
7m

Are you interested in #rarecancers, #MDS, #diversity and #equity, or #pateintreportedoutcomes? Check out our upcoming public meetings this spring and sign up for free public discussions and workshops. Then bookmark this page to stay connected! 📅 🌸 🌞
https://www.fda.gov/about-fda/oncology-center-excellence/oce-meetings-and-workshops

Reply on Twitter 1641930622049435648 Retweet on Twitter 1641930622049435648 Like on Twitter 1641930622049435648 Twitter 1641930622049435648
nature nature @nature ·
9m

Audio long read: What Turkey’s earthquake tells us about the science of seismic forecasting https://go.nature.com/40x4EJ1

Reply on Twitter 1641929943272636417 Retweet on Twitter 1641929943272636417 Like on Twitter 1641929943272636417 6 Twitter 1641929943272636417
sotoxicology SOT @sotoxicology ·
15m

The @EPA is looking for scientific and technical experts to serve as ad hoc reviewers assisting the Federal Insecticide, Fungicide, and Rodenticide Act Scientific Advisory Panel. Nominations are due April 24: https://bit.ly/42Zl12K via @FedRegister

Reply on Twitter 1641928629884973058 Retweet on Twitter 1641928629884973058 Like on Twitter 1641928629884973058 Twitter 1641928629884973058
Retweet on Twitter American College of Medical Toxicology Retweeted
davidjuurlink David Juurlink @davidjuurlink ·
41m

Tips for managing buprenorphine-precipitated withdrawal #ACMT2023

Reply on Twitter 1641922089639657472 Retweet on Twitter 1641922089639657472 1 Like on Twitter 1641922089639657472 7 Twitter 1641922089639657472
Load More...

Contact Us

info@mdpharma.ca

+1-905-315-5043

4145 North Service Road, 2nd Floor, Burlington ON L7L6A3 Canada

Follow Us On Twitter

Follow Us On LinkedIn

Recent News

  • Insulin Resistance – What does it mean?
  • 5-minute weekly newscast – 23/06/2019
  • 5-minute weekly newscast – 16/06/2019
  • 5-minute weekly newscast – 09/06/2019
  • 5-minute weekly newscast – 02/06/2019

Resources

  • Privacy Policy
  • Cookie Policy

About Us

An extremely talented, diversely innovative, science driven, quality focused team providing novel medical consultations to pharmaceutical and medical device incorporations.

We streamline clinical operations to deliver efficacious solutions for complex projects.

Supporting drug development pipelines from benchside to "market"side is our top priority.

We provide our services across Canada and the United States.

© 2020 MD Pharma Consulting Group. All Rights Reserved.